SCHEMBL3262397

SCHEMBL3262397

c1ccc(NC2CCSCC2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 1/20 0.49
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
PKM P14618 1/20 0.43
MAPT P10636 1/20 0.42
GPR39 O43194 1/20 0.42
MEN1 O00255 1/20 0.41
MAPK10 P53779 1/20 0.41
GFER P55789 1/20 0.41
KMT2A Q03164 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
PIM1 P11309 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
FLT3 P36888 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20777354 0.90 NOS2 (0.44) NOS2HDAC8HDAC6NPC1RAB9A
SCHEMBL526424 0.87 NOS2 (0.55) NOS2HDAC8HDAC6NPC1RAB9A
Hydrochloric Acid SCHEMBL1919379 0.85 NOS2 (0.54) NOS2HDAC8HDAC6NPC1RAB9A
SCHEMBL16548498 0.83 ALDH1A1 (0.58) NOS2NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7919601 0.83 ALDH1A1 (0.54) NOS2HDAC8HDAC6NPC1RAB9A
SCHEMBL1579641 0.81 KDM4E (0.60) NOS2SMN1; SMN2ALDH1A1MAPTGPR39
SCHEMBL29211498 0.80 KDM4E (0.58) NOS2SMN1; SMN2ALDH1A1MAPTGPR39
SCHEMBL25091032 0.79 NOS2 (0.52) NOS2HDAC8HDAC6NPC1RAB9A
SCHEMBL3235320 0.79 MAPK1 (0.62) NOS2NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL17730328 0.79 MERTK (0.55) NOS2HDAC8HDAC6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010030360-A1 3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2010-03-18 WO disclosed